| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5890946 | Bone | 2013 | 5 Pages | 
Abstract
												In vitamin D-deficient hip fracture patients, oral supplementation with cholecalciferol and ergocalciferol had no effect on total serum 1,25(OH)2D, and comparable effects on DBP and free vitamin D metabolite concentrations. This is despite cholecalciferol having greater effects than ergocalciferol in increasing total 25OHD, and in increasing ionized calcium in treatment-adherent subjects. These findings may explain why cholecalciferol and ergocalciferol supplementation result in similar magnitudes of PTH reduction, but implicate potential differences in other vitamin D metabolites, such as 24,25(OH)2D, that could explain their different effects on ionized calcium.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Developmental Biology
												
											Authors
												Paul Glendenning, Gerard T. Chew, Charles A. Inderjeeth, Mario Taranto, William D. Fraser, 
											